InnovHeart fetches Series B

Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing.

ByIris Dorbian

7 August 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

InnovHeart fetches Series B

CDP Venture Capital

Indaco Venture Partners SGR SPA

Panakes Partners

Related articles